BlackRock Fund Advisors - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 42 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2015$44,000
-6.4%
50,0000.0%0.00%
Q2 2015$47,00050,0000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
Context Capital Management, LLC 4,420,000$3,547,0005.52%
Park West Asset Management LLC 28,535,000$22,846,0002.47%
ZAZOVE ASSOCIATES LLC 22,590,000$18,016,0000.85%
IRON Financial LLC 1,170,000$960,0000.82%
WHITEBOX ADVISORS LLC 14,716,000$11,782,0000.32%
AQR Arbitrage LLC 23,475,000$18,912,0000.21%
PRELUDE CAPITAL MANAGEMENT, LLC 1,500,000$1,208,0000.19%
Pinnacle Summer Investments, Inc. 16,672,000$916,0000.14%
WOLVERINE ASSET MANAGEMENT LLC 7,679,000$6,104,0000.13%
OAKTREE CAPITAL MANAGEMENT LP 8,296,000$6,595,0000.09%
View complete list of PDL BIOPHARMA INC shareholders